Results 141 to 150 of about 24,724 (196)

The Role of DNA Methylation in Osteosarcoma Pathogenesis and Therapy. [PDF]

Onco Targets Ther
Zhou X, Li B, Tao P.
europepmc   +1 more source

Decitabine-Driven Foetal Haemoglobin Induction in Townes Mice and Human Erythroblasts. [PDF]

EJHaem
Carol Illa A, Chin DWL, Clark M, Petersen J, Skov S, Glenthøj A, Ley CD.   +6 more
europepmc   +1 more source

Single-molecule tracking of DNMT1 in living cells reveals its cell cycle dynamics and its redistribution upon drug treatment. [PDF]

Nucleic Acids Res
Lee ES, Tommer ER, Rothman PB, Middleton SV, Youmans DT, Cech TR.   +5 more
europepmc   +1 more source

p53 status determines the epigenetic response to demethylating agents azacitidine and decitabine. [PDF]

EMBO Rep
Hands EL, Wallmann A, Oxley G, Storrar S, D'Souza R, Van de Pette M.   +5 more
europepmc   +1 more source

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML. [PDF]

Blood Adv
Garcia JS, Kim HT, Murdock HM, Bosch-Vilaseca A, Panaro KM, Lim F, Fiorilla J, Auriemma E, Brock J, Gooptu M, Ho VT, Cutler CS, Shapiro R, Kelkar AH, Abel GA, DeAngelo DJ, Stone RM, Bat-Erdene D, Ryan J, Fell G, Letai A, Ritz J, Lindsley RC, Antin JH, Soiffer RJ.   +24 more
europepmc   +1 more source

A New Targeted Therapy Strategy for Lymphoma. [PDF]

MedComm (2020)
Gale RP.
europepmc   +1 more source

Mechanism of action of decitabine in treating acute lymphoblastic leukemia. [PDF]

Front Med (Lausanne)
Gao X, Zeng H, Sun F, Zhao X, Wu H, Yan M, Li Y, Fu Q, Zhang G.   +8 more
europepmc   +1 more source

Correction to "Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine". [PDF]

Cancer Sci
europepmc   +1 more source

Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRD. [PDF]

Hematology Am Soc Hematol Educ Program
Schonewille P, van Rhenen A, Ham RMT, de Witte M, Kuball J.   +4 more
europepmc   +1 more source

Increasing TET expression and 5-hydroxymethylcytosine formation by a carbocyclic 5-aza-2’-deoxy-cytidine antimetabolite

Däther M, Peev E, Fröhlich A, Vick B, Fatourechi S, Gasparoni G, Heiss M, Pleintinger CC, Bisong EA, Hurmiz H, Guglielminotti D, Gärtner YV, Aumer T, Spiekermann K, Walter J, Jeremias I, Traube FR, Carell T.   +17 more
europepmc   +1 more source